Impact of Letermovir Prophylaxis on Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis
Latest Information Update: 26 Mar 2026
At a glance
- Drugs Letermovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
Most Recent Events
- 26 Mar 2026 New trial record